In our study, the IC50 of cisplatin and docetaxel were higher in TRIM31-high group, indicated high expression of TRIM31 may contributed to the resistance of cisplatin and docetaxel in GC tumor cells. The gene discussed is TRIM31; the disease is neoplasm.